• ABT-263 (Navitoclax): Protocol-Driven Advances in Apoptosis

  2026-05-05

  ABT-263 (Navitoclax) enables high-sensitivity, caspase-dependent apoptosis assays across diverse cancer models, with nanomolar potency and robust protocol guidance. Explore how APExBIO’s solution empowers researchers to dissect therapy-induced senescence and optimize workflow reproducibility.

• Cisplatin (CDDP) in Translational Oncology: Mechanisms & Str

  2026-05-05

  This thought-leadership article explores the mechanistic foundation and translational strategy for leveraging Cisplatin (CDDP) in overcoming platinum resistance, with actionable protocol guidance for cancer researchers. Drawing on recent evidence, including the pivotal role of CLK2 in chemoresistance, the discussion integrates experimental recommendations and product intelligence for APExBIO's Cisplatin.

• Iron Stress Alters Enterocyte Metabolism: Insights from IPEC

  2026-05-04

  Navazesh and Ji (2025) provide a metabolomic and transcriptional analysis of how iron deficiency and excess reshape enterocyte metabolism using the IPEC-J2 cell model. Their study demonstrates that iron imbalance disrupts proliferation, energy production, and inflammatory signaling—findings with implications for gut health, pediatric nutrition, and iron chelation research.

• PFOS-Induced Ferroptosis and ER Stress in HK-2 Kidney Cells

  2026-05-04

  This study identifies that perfluorooctane sulfonate (PFOS) induces injury in human kidney HK-2 cells via coordinated ferroptosis and endoplasmic reticulum (ER) stress pathways. The mechanistic insights into these injury processes provide a foundation for evaluating nephrotoxicity and developing cellular stress modulation strategies.

• LY294002: Applied PI3K/Akt/mTOR Inhibition in Cancer & Cell

  2026-05-03

  LY294002 from APExBIO offers robust, reversible inhibition of class I PI3Ks, enabling precise dissection of the PI3K/Akt/mTOR pathway across cancer and cell biology models. Explore practical workflows, advanced troubleshooting, and key protocol optimizations that unlock its full experimental potential.

• Deferiprone in Cancer Biology: Optimizing Iron Modulation As

  2026-05-02

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) delivers precise, reproducible control over intracellular iron, enabling researchers to dissect iron-dependent pathways in cancer biology and metabolic studies. Advanced workflows and troubleshooting insights make APExBIO’s Deferiprone a gold-standard reagent for both mechanistic and translational research.

• Catalpol in Translational Research: Mechanisms and Strategy

  2026-05-02

  Explore how Catalpol’s multi-target mechanisms and robust preclinical efficacy are reshaping translational disease modeling, with strategic guidance for researchers seeking to bridge mechanistic insight and clinical innovation.

• IR-1061: Near Infrared Fluorescent Dye for Deep Tissue Imagi

  2026-05-01

  IR-1061, a robust near infrared fluorescent dye, enables high-clarity, deep-tissue in vivo imaging using streamlined polymer encapsulation workflows. This guide translates recent reference breakthroughs into actionable protocols, comparative insights, and troubleshooting strategies for biomedical researchers.

• Advancing In Vitro Drug Response Evaluation in Cancer Resear

  2026-04-30

  Schwartz's dissertation introduces refined in vitro methodologies to dissect drug-induced proliferation arrest and cell death, clarifying their distinct contributions to anticancer drug responses. This work improves the interpretability and translational relevance of preclinical cancer drug screening.

• Silymarin (Silybin A): Precision Workflows for Liver Researc

  2026-04-30

  Silybin A, the principal bioactive of Silymarin, is redefining hepatoprotective and metabolic research through validated protocols that maximize assay reproducibility. This article translates seminal reference chemistry and cross-study insights into actionable workflows, troubleshooting strategies, and advanced use-cases for next-generation liver disease and oxidative stress research.

• Ibuprofen Beyond COX Inhibition: Mechanistic Insights for Ca

  2026-04-29

  Explore the multifaceted role of Ibuprofen (2-[4-(2-methylpropyl)phenyl]propanoic acid) in cancer research, emphasizing its apoptosis induction and lipid modulation. This article offers a deeper mechanistic and contextual analysis, setting it apart from standard NSAID workflows.

• Probenecid: Mechanistic Leverage for Translational Research

  2026-04-29

  This thought-leadership article explores Probenecid (4-(dipropylsulfamoyl)benzoic acid) as a multifaceted tool for overcoming multidrug resistance and driving neuroprotection in translational workflows. Integrating mechanistic insights with strategic guidance, it contextualizes Probenecid’s unique actions on organic anion transporters, MRPs, and pannexin-1 channels within the evolving landscape of immunometabolic research—including metabolic flexibility in CD8+ T cells—while offering actionable recommendations and protocol guidance for researchers.

• Biotin-tyramide: Precision Signal Amplification for Spatial

  2026-04-28

  Biotin-tyramide is a high-purity biotin phenol reagent that enables enzyme-mediated signal amplification in immunohistochemistry and in situ hybridization. Its HRP-catalyzed mechanism underpins ultrasensitive, spatially resolved detection. This article details its molecular action, evidentiary benchmarks, and workflow integration for advanced biological imaging.

• Diclofenac for COX Inhibition in Intestinal Organoid Assays

  2026-04-28

  Diclofenac, a non-selective COX inhibitor, enables highly reproducible inflammation and pain signaling studies in advanced human iPSC-derived intestinal organoid models. Leveraging APExBIO’s high-purity compound with robust workflow parameters ensures precise cyclooxygenase inhibition and pharmacokinetic assessment, bridging translational gaps in anti-inflammatory drug research.

• Everolimus (RAD001) in Cancer Research: Workflows & Solution

  2026-04-27

  Everolimus (RAD001) empowers translational cancer research with precise mTOR pathway inhibition for robust apoptosis and proliferation assays. This article delivers actionable protocols, advanced troubleshooting, and integration of the latest in vitro evaluation strategies to maximize data fidelity and reproducibility.

448 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page